Jove
Visualize
Contact Us

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination of 2D and 3D nnU-Net for ground glass opacity segmentation in CT images of Post-COVID-19 patients.

Computers in biology and medicine·2025
Same author

From SMILES to Enhanced Molecular Property Prediction: A Unified Multimodal Framework with Predicted 3D Conformers and Contrastive Learning Techniques.

Journal of chemical information and modeling·2024
Same author

An efficient hybrid deep learning architecture for predicting short antimicrobial peptides.

Proteomics·2024
Same author

eMIC-AntiKP: Estimating minimum inhibitory concentrations of antibiotics towards <i>Klebsiella pneumoniae</i> using deep learning.

Computational and structural biotechnology journal·2023
Same author

Identifying Transcription Factors That Prefer Binding to Methylated DNA Using Reduced <i>G</i>-Gap Dipeptide Composition.

ACS omega·2022
Same author

BeCaked: An Explainable Artificial Intelligence Model for COVID-19 Forecasting.

Scientific reports·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary surgical management refractory glaucoma: tubes as initial surgery.

Quang H Nguyen1

  • 1Glaucoma Service, Division of Ophthalmology, Scripps Clinic, La Jolla, California, USA. Nguyen.Quang@scrippshealth.org

Current Opinion in Ophthalmology
|February 26, 2009
PubMed
Summary
This summary is machine-generated.

Glaucoma drainage implants show comparable efficacy and safety to traditional trabeculectomy. These implants may offer better outcomes when used earlier in glaucoma treatment, expanding their surgical role.

Related Experiment Videos

Area of Science:

  • Ophthalmology
  • Surgical Innovation

Background:

  • Glaucoma drainage implants are increasingly considered for surgical glaucoma management.
  • Traditionally, trabeculectomy is the primary surgical choice, with implants reserved for high-risk cases.
  • A consensus gap exists among surgeons regarding tube shunts versus trabeculectomy.

Purpose of the Study:

  • To review the evolving role of glaucoma drainage implants in surgical glaucoma treatment.
  • To compare the efficacy and safety of glaucoma drainage implants with trabeculectomy.
  • To explore the potential benefits of using glaucoma drainage implants as an initial surgical procedure.

Main Methods:

  • Review of peer-reviewed publications comparing glaucoma drainage implants and trabeculectomy.
  • Analysis of intraocular pressure reduction and safety profiles.
  • Consideration of treatment outcomes based on surgical timing (initial vs. refractory glaucoma).

Main Results:

  • Glaucoma drainage implants demonstrate similar efficacy and safety to trabeculectomy with antimetabolites.
  • The Tube Versus Trabeculectomy (TVT) study showed comparable intraocular pressure reduction at one year.
  • Perceived lower success rates for implants may stem from their historical use in refractory cases.

Conclusions:

  • Glaucoma drainage implants should play an expanding role in the surgical treatment of glaucoma.
  • Early use of glaucoma drainage implants may yield different intraocular pressure control outcomes.
  • Further research may clarify optimal patient selection for initial glaucoma implant surgery.